Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs glimepiride on subclinical heart failure in type 2 diabetes
2010-022695-31Phase 2Active
- Sponsor
- Karolinska Institutet
- Start
- Feb 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of liraglutide in type 2 diabetes mellitus (T2DM) and heart failure (HF) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Primary: Improvement in left ventricle longitudinal function and/or functional reserve. Started Feb 2011; status: active.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on 2010-022695-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022695-31.